Back
CSPC Pharmaceutical Group Quote, Financials, Valuation and Earnings
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!
Buy
66
CSPCY
CSPC Pharmaceutical Group
Last Price:
3.44
Seasonality Move:
6.88%
7 Day Trial
ALL ACCESS PASS
$
7
Stock Market Legend Shares Biggest Prediction Ever:
Click Here to SeeCSPC Pharmaceutical Group Price Quote
$3.44
CSPC Pharmaceutical Group Key Stats
Buy
66
CSPC Pharmaceutical Group (CSPCY)
is a Buy
Day range:
$3.40 - $3.44
52-week range:
$2.63 - $4.08
Dividend yield:
3.71%
P/E ratio:
12.30
P/S ratio:
2.29
P/B ratio:
2.18%
Volume:
11.2K
Avg. volume:
35K
1-year change:
-12.91%
Market cap:
$10.2B
Revenue:
$4.4B
EPS:
$0.28
How Much Does CSPC Pharmaceutical Group Make?
-
How Much Are CSPC Pharmaceutical Group's Sales Annually?
CSPCY Revenues are $4.4B -
How Much Profit Does CSPC Pharmaceutical Group's Make A Year?
CSPCY net income is $830.3M
Is CSPC Pharmaceutical Group Growing As A Company?
-
What Is CSPC Pharmaceutical Group's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.01% -
What Is CSPC Pharmaceutical Group's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.16%
CSPC Pharmaceutical Group Stock Price Performance
-
Did CSPC Pharmaceutical Group Stock Go Up Last Month?
CSPC Pharmaceutical Group share price went up by 10.97% last month -
Did CSPCY's Share Price Rise Over The Last Year?
CSPCY share price fell by -12.91% over the past 1 year
What Is CSPC Pharmaceutical Group 52-Week High & Low?
-
What Is CSPC Pharmaceutical Group’s 52-Week High Share Price?
CSPC Pharmaceutical Group has traded as high as $4.08 over the past 52 weeks -
What Is CSPC Pharmaceutical Group’s 52-Week Low Share Price?
CSPC Pharmaceutical Group has traded as low as $2.63 over the past 52 weeks
CSPC Pharmaceutical Group Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy CSPC Pharmaceutical Group?
-
How Much Debt Does CSPC Pharmaceutical Group Have?
Total long term debt quarterly is $63.5M -
How Much Cash Does CSPC Pharmaceutical Group Have?
Cash and short term investments quarterly total is $1.8B -
What Is CSPC Pharmaceutical Group’s Book Value Per Share?
Book value per share is 1.57
Is CSPC Pharmaceutical Group Cash Flow Positive?
Data Unavailable
CSPC Pharmaceutical Group Return On Invested Capital
-
Is Management Doing A Good Job?
CSPCY return on invested capital is 17.5% -
What Is CSPC Pharmaceutical Group Return On Assets?
ROA measures how assets are converting to revenues and is 13.4% -
What Is CSPCY Return On Equity?
ROE is a measure of profitability and is 18.27%
CSPC Pharmaceutical Group Earnings Date & Stock Price
-
What Is CSPC Pharmaceutical Group's Stock Price Today?
A single share of CSPCY can be purchased today for 3.44 -
What Is CSPC Pharmaceutical Group’s Stock Symbol?
CSPC Pharmaceutical Group trades on the otcm under the ticker symbol: CSPCY -
When Is CSPC Pharmaceutical Group’s Next Earnings Date?
The next quarterly earnings date for CSPC Pharmaceutical Group is scheduled on September 13, 2024 -
When Is CSPCY's next ex-dividend date?
CSPC Pharmaceutical Group's next ex-dividend date is June 3, 2024 -
How To Buy CSPC Pharmaceutical Group Stock?
You can buy CSPC Pharmaceutical Group shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
CSPC Pharmaceutical Group Competitors
-
Who Are CSPC Pharmaceutical Group's Competitors?
Below is a list of companies who compete with CSPC Pharmaceutical Group or are related in some way:
CSPC Pharmaceutical Group Dividend Yield
-
What Is CSPCY Dividend Yield?
CSPC Pharmaceutical Group’s dividend yield currently is 3.71% -
What Is CSPC Pharmaceutical Group’s Payout Ratio?
CSPC Pharmaceutical Group’s payout ratio is 20.67% -
When Did CSPC Pharmaceutical Group Last Pay A Dividend?
The latest dividend pay date is May 4, 2024 -
What Is CSPC Pharmaceutical Group’s Dividend Per Share?
CSPC Pharmaceutical Group pays a dividend of $0.00 per share
CSPC Pharmaceutical Group Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | -15.61% | 0% |
| Revenue: | 0.74% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |